Business · 1 sources covering this

CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses

Indian drug regulators ordered Sun Pharma to halt eye-care drug production at its Assam plant over quality lapses, following the recall of 332 batches of ophthalmic products.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses
Indian drug regulators ordered Sun Pharma to halt eye-care drug production at its Assam plant over quality lapses, following the recall of 332 batches of ophthalmic products.
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/f5c69a931ddfa2c8eaca820c02e461aeedf39bd3"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses"></iframe>

CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses

How 1 sources are covering this

CDSCO asks Sun Pharma to halt eye-care drug production over quality lapses

More from Business

Sun TV Q2: Revenue Falls 27%, Rs 3.75 Interim Dividend Declared

GRSE, Goa Shipyard To Build 8 Next-Gen Navy Corvettes Under Rs 40,000 Crore Deal

Jiyaa Shankar Unfollows Fiancé Kaaran Dhanak On Instagram, Shares Cryptic Posts 'Tables Eventually Turn’

Syrma SGS Q2 Results: Net Profit Jumps 83% Even As Margin Contracts

Reader

Trust & legal

Across the network